Total Funding
73
64
Total FundingVenture - Series Unknown raised
Growth Score
-14 pts
Heat Score
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
26017
Marius Pharmaceuticals is a biopharmaceutical company that brings novel treatments to a range of diseases with unmet medical needs.
Om Dhingra: Vice Chairman & Co-Founder- Roger Rittmaster: Chief Medical Officer
About the Company
Marius Pharmaceuticals is a biopharmaceutical company that develops oral testosterone replacement therapy to bring novel treatments to a range of diseases with unmet medical needs. The company's solutions overcome many of the problems associated with currently approved products and their proprietary delivery technology has reached optimal
absorption with all meal types resulting in a higher bioavailability, providing men suffering from low testosterone with safe and efficacious treatment.
The company was founded in 2017 and headquartered in Raleigh, North Carolina.
